Evidence map›Paper›PMID 23916682›Full record

ArticleJournal of pain and symptom management2014

Proteomic serum profile of fatigued men receiving localized external beam radiation therapy for non-metastatic prostate cancer.

Nada Lukkahatai, Sajni Patel, Marjan Gucek, Chao-Pin Hsiao, Leorey N Saligan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of pain and symptom management, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nada LukkahataiNational Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: nada.lukkahatai@nih.gov.
Sajni PatelNational Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Marjan GucekNational Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Chao-Pin HsiaoNational Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland, USA.
Leorey N SaliganNational Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland, USA.
National Institute of Nursing Research · USNational Institutes of Health · USNational Heart Lung and Blood Institute · US

Funding

Proteomics CoreZICHL005903 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI GUCEK, MARJAN · 2009 to 2022
$23.3M
Intramural NIH HHS Z99 NR999999
6 · The paper itself

Abstract

contextFatigue is the most distressing side effect of radiation therapy, and its progression etiology is unknown.

objectivesThis study describes proteome changes from sera of fatigued men with non-metastatic prostate cancer receiving external beam radiation therapy (EBRT).

methodsFatigue scores, measured by the Functional Assessment of Chronic Illness Therapy-Fatigue, and serum were collected from 12 subjects at baseline (before EBRT) and at midpoint (Day 21) of EBRT. Depleted sera from both time points were analyzed using two-dimensional difference gel electrophoresis, and up/down regulated proteins were identified using liquid chromatography-tandem mass spectrometry. Western blot analyses confirmed the protein changes observed.

resultsResults showed that apolipoprotein (Apo)A1, ApoE, and transthyretin (TTR) consistently changed from baseline (Day 0) to midpoint (Day 21). The mean ApoE level of subjects with high change in fatigue (HF: n = 9) increased significantly from baseline to midpoint and were higher than in subjects with no change in fatigue. The mean ApoA1 level was higher in HF subjects at baseline and at midpoint than in no fatigue subjects at both time points. The mean TTR level of no fatigue subjects was higher at baseline and midpoint than in HF subjects.

conclusionThese ApoE, ApoA1, and TTR results may assist in understanding pathways that can explain fatigue progression etiology in this clinical population.

Indexed as

AgedApolipoprotein A-IApolipoproteins EBlotting, WesternChromatography, LiquidDisease ProgressionFatigueHumansMaleMiddle AgedPrealbuminProstatic NeoplasmsProteomicsSeverity of Illness IndexTandem Mass SpectrometryTime FactorsAPOA1 protein, humanApolipoprotein A-IApolipoproteins EPrealbuminExternal beam radiation therapyfatigueprostate cancerquantitative proteomicsWestern blot

Identifiers

PMID23916682
PMCPMC3743082
OpenAlexW2052366689

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.